Market Cap | 1.52M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -233.84k | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 3.00% |
Sales | 800 | PEG | - | EPS past 5Y | - | 200D Avg Chg | -15.00% |
Dividend | N/A | Price/Book | 4.26 | EPS next 5Y | - | 52W High Chg | -70.00% |
Recommedations | - | Quick Ratio | - | Shares Outstanding | 50.07M | 52W Low Chg | 45.00% |
Insider Own | - | ROA | -2.58% | Shares Float | 29.57M | Beta | -2.52 |
Inst Own | - | ROE | -5.06% | Shares Shorted/Prior | -/- | Price | 0.14 |
Gross Margin | 100.00% | Profit Margin | - | Avg. Volume | 7,983 | Target Price | - |
Oper. Margin | -30,974.50% | Earnings Date | Oct 7 | Volume | 35,443 | Change | 11.38% |
Signal Advance, Inc. engages in the engineering research and technology development business. The company offers Signal Advance (SA) technology that reduces signal detection delays associated with various physical sensors, as well as reduction in response time, which includes improved performance in control, intervention, and signal transmission systems. It serves biomedicine, transportation, cyber-security, industrial control system, communication, and defense markets. The company was formerly known as Biodyne Development Company, Inc and changed its name to Signal Advance, Inc. in 2007. The company was incorporated in 1992 and is based in Rosharon, Texas.